Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication

Eliezer Kaufman, Kenneth M Hargreaves, Raymond A. Dionne

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Triazolam was evaluated as an oral sedative agent for dental outpatients in two studies in the oral surgery model. The first study demonstrated that 0.25 mg of triazolam in combination with nitrous oxide provides therapeutic effects but with a more rapid recovery than a 0.50 mg dose in combination with nitrous oxide. In the second study, triazolam produced a significant anxiolytic effect that was comparable to the effects of diazepam titrated to the usual clinical endpoint (mean dose = 19.3 mg). Less impairment in cognitive-psychomotor impairment and ambulatory function was seen after triazolam in comparison with diazepam. Triazolam appears to be a safe, effective alternative to parenteral sedation with a benzodiazepine for dental outpatients.

Original languageEnglish (US)
Pages (from-to)156-164
Number of pages9
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume75
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Triazolam
Premedication
Nitrous Oxide
Diazepam
Outpatients
Placebos
Tooth
Psychomotor Disorders
Oral Surgery
Anti-Anxiety Agents
Therapeutic Uses
Hypnotics and Sedatives
Benzodiazepines

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication. / Kaufman, Eliezer; Hargreaves, Kenneth M; Dionne, Raymond A.

In: Oral Surgery, Oral Medicine, Oral Pathology, Vol. 75, No. 2, 1993, p. 156-164.

Research output: Contribution to journalArticle

@article{c4527c14d10b401892fa79dcab6d068a,
title = "Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication",
abstract = "Triazolam was evaluated as an oral sedative agent for dental outpatients in two studies in the oral surgery model. The first study demonstrated that 0.25 mg of triazolam in combination with nitrous oxide provides therapeutic effects but with a more rapid recovery than a 0.50 mg dose in combination with nitrous oxide. In the second study, triazolam produced a significant anxiolytic effect that was comparable to the effects of diazepam titrated to the usual clinical endpoint (mean dose = 19.3 mg). Less impairment in cognitive-psychomotor impairment and ambulatory function was seen after triazolam in comparison with diazepam. Triazolam appears to be a safe, effective alternative to parenteral sedation with a benzodiazepine for dental outpatients.",
author = "Eliezer Kaufman and Hargreaves, {Kenneth M} and Dionne, {Raymond A.}",
year = "1993",
doi = "10.1016/0030-4220(93)90086-J",
language = "English (US)",
volume = "75",
pages = "156--164",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication

AU - Kaufman, Eliezer

AU - Hargreaves, Kenneth M

AU - Dionne, Raymond A.

PY - 1993

Y1 - 1993

N2 - Triazolam was evaluated as an oral sedative agent for dental outpatients in two studies in the oral surgery model. The first study demonstrated that 0.25 mg of triazolam in combination with nitrous oxide provides therapeutic effects but with a more rapid recovery than a 0.50 mg dose in combination with nitrous oxide. In the second study, triazolam produced a significant anxiolytic effect that was comparable to the effects of diazepam titrated to the usual clinical endpoint (mean dose = 19.3 mg). Less impairment in cognitive-psychomotor impairment and ambulatory function was seen after triazolam in comparison with diazepam. Triazolam appears to be a safe, effective alternative to parenteral sedation with a benzodiazepine for dental outpatients.

AB - Triazolam was evaluated as an oral sedative agent for dental outpatients in two studies in the oral surgery model. The first study demonstrated that 0.25 mg of triazolam in combination with nitrous oxide provides therapeutic effects but with a more rapid recovery than a 0.50 mg dose in combination with nitrous oxide. In the second study, triazolam produced a significant anxiolytic effect that was comparable to the effects of diazepam titrated to the usual clinical endpoint (mean dose = 19.3 mg). Less impairment in cognitive-psychomotor impairment and ambulatory function was seen after triazolam in comparison with diazepam. Triazolam appears to be a safe, effective alternative to parenteral sedation with a benzodiazepine for dental outpatients.

UR - http://www.scopus.com/inward/record.url?scp=0027415587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027415587&partnerID=8YFLogxK

U2 - 10.1016/0030-4220(93)90086-J

DO - 10.1016/0030-4220(93)90086-J

M3 - Article

C2 - 8426714

AN - SCOPUS:0027415587

VL - 75

SP - 156

EP - 164

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 2

ER -